Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to to determine the safety and effectiveness of therapeutic
combination - Clofarabine and Cytarabine for the treatment of AML and MDS.